Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, has appointed Dr Hazel Jones as chief operating officer.  Following a £10 million Series A financing in October 2022, Dr Jones’s appointment is the next step in the company’s drive to broaden the application of its technology … Continue reading MedTech appoints COO from AstraZeneca